Picture of Inozyme Pharma logo

INZY — Inozyme Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Inozyme Pharma Reports First Quarter 2023 Financial Results And Provides Business Highlights

Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND
PROVIDES BUSINESS HIGHLIGHTS
    * CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
ANTICIPATED TO FUND CASH FLOW REQUIREMENTS INTO Q4 OF 2024
    * QTRLY NET LOSS PER SHARE $0.40
    * Q1 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX39zXtp 
Further company coverage:  INZY.O

Recent news on Inozyme Pharma

See all news